BUSINESS● LOWAug 13 · Aug 13, 2026, 8:30 PM
ARS Pharmaceuticals GAAP EPS of -$0.63 misses by $0.14, revenue of $33.7M beats by $2.38M
Seeking Alpha Tech
ARS Pharmaceuticals reported GAAP EPS of -$0.63, missing estimates, while revenue of $33.7 million exceeded expectations. This details the company's financial performance relative to market predictions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS45m agoGold market consolidating rather than entering bear market, Metals Focus analyst saysSeeking Alpha TechBUSINESS46m agoCollegium resolves Nucynta patent dispute with GrünenthalSeeking Alpha Tech